文献速递重症综合管理与镇静镇痛心脑血管急症呼吸衰竭与机械通气

静脉-静脉体外膜氧合期间缺血性与出血性卒中的危险因素:体外生命支持组织登记数据分析

Risk Factors of Ischemic and Hemorrhagic Strokes During Venovenous Extracorporeal Membrane Oxygenation: Analysis of Data From the Extracorporeal Life Support Organization Registry.
PubMed 文献 · Crit Care Med · 2021-01-01
一句话结论VV-ECMO患者约5%发生急性脑损伤,缺血/出血性卒中使院内死亡率翻倍至68%/73%,低pH、低氧及凝血紊乱是独立危险因素。

该回顾性分析基于体外生命支持组织(ELSO)2013–2019年366个中心上报数据,纳入15,872例接受单次VV-ECMO的成人患者。812例(5.1%)发生至少一种急性脑损伤(缺血性卒中、出血性卒中或脑死亡),其中缺血性卒中215例(1.4%)、出血性卒中484例(3.1%)。总体院内死亡率36%,发生缺血性或出血性卒中者分别升至68%和73%。多因素分析显示,插管前低pH、溶血、消化道出血、弥散性血管内凝血与缺血性卒中独立相关;插管前低pH、低Po2、消化道出血及肾脏替代治疗与出血性卒中独立相关。

要点

  • VV-ECMO成人患者中5.1%(812/15,872)发生急性脑损伤,缺血性卒中1.4%、出血性卒中3.1%。
  • 发生缺血性或出血性卒中者院内死亡率分别为68%和73%,显著高于总体36%。
  • 缺血性卒中独立危险因素:插管前低pH(aOR=0.10)、溶血(aOR=2.27)、消化道出血(aOR=2.01)、DIC(aOR=3.61)。
  • 出血性卒中独立危险因素:插管前低pH(aOR=0.28)、低Po2(aOR=0.96)、消化道出血(aOR=1.70)、肾脏替代治疗(aOR=1.57)。
  • 凝血紊乱标志物(溶血、DIC、消化道出血)与缺血性卒中相关,提示ECMO期间需关注凝血状态与脑损伤风险。

适用人群与场景

  • 成人(>18岁)接受单次静脉-静脉体外膜氧合(VV-ECMO)支持的患者,数据来自2013–2019年ELSO登记库366个中心。

诊断标准与关键阈值

  • 急性脑损伤定义为缺血性卒中、出血性卒中或脑死亡。
  • 缺血性卒中215例(1.4%),出血性卒中484例(3.1%),至少一种急性脑损伤812例(5.1%)。

处置流程与药物剂量

  • 原文未提及

红旗征与不能漏的情况

  • 发生缺血性卒中者院内死亡率68%,出血性卒中者73%,均显著高于总体36%,提示一旦出现卒中征象需高度警惕并积极处理。
  • 插管前低pH、低Po2、溶血、消化道出血、DIC及肾脏替代治疗为独立危险因素,应纳入监测与风险评估。

研究设计与关键结果

  • 研究类型:回顾性分析ELSO登记数据,366个中心,2013–2019年,15,872例成人单次VV-ECMO患者。
  • 主要结果:812例(5.1%)发生至少一种急性脑损伤;缺血性卒中215例(1.4%),出血性卒中484例(3.1%)。
  • 院内死亡率:总体36%,缺血性卒中68%,出血性卒中73%。
  • 缺血性卒中多因素分析:插管前pH aOR=0.10(95%CI 0.03–0.35,p<0.001);溶血aOR=2.27(95%CI 1.22–4.24,p=0.010);消化道出血aOR=2.01(95%CI 1.12–3.59,p=0.019);DIC aOR=3.61(95%CI 1.51–8.66,p=0.004)。
  • 出血性卒中多因素分析:插管前pH aOR=0.28(95%CI 0.12–0.65,p=0.003);插管前Po2 aOR=0.96(95%CI 0.93–0.99,p=0.021);消化道出血aOR=1.70(95%CI 1.15–2.51,p=0.008);肾脏替代治疗aOR=1.57(95%CI 1.22–2.02,p<0.001)。

证据类型、等级与局限

  • 证据类型:回顾性登记数据分析(ELSO registry),非随机对照试验。
  • 局限:回顾性设计,依赖自愿上报数据,可能存在报告偏倚与混杂;原文未提及证据等级。

对床旁实践的改变

  • VV-ECMO患者应警惕急性脑损伤,尤其插管前存在低pH、低氧、溶血、消化道出血、DIC或需肾脏替代治疗者。
  • 发生缺血性或出血性卒中后院内死亡率显著升高(68%/73%),提示需加强神经系统监测与早期识别。
  • 原文未提及具体预防或治疗策略,需进一步研究确定时机与干预措施。

指南或共识出处

  • Extracorporeal Life Support Organization (ELSO) Registry 数据,2013–2019年,发表于 Critical Care Medicine。

以上提炼依据论文摘要(全文未开放获取,或许可不允许翻译转载);全文请点「阅读原文」。

英文原文(摘要)· 点击展开

OBJECTIVES: Stroke is commonly reported in patients receiving venovenous extracorporeal membrane oxygenation, but risk factors are not well described. We sought to determine preextracorporeal membrane oxygenation and on-extracorporeal membrane oxygenation risk factors for both ischemic and hemorrhagic strokes in patients with venovenous extracorporeal membrane oxygenation support.

DESIGN: Retrospective analysis.

SETTING: Data reported to the Extracorporeal Life Support Organization by 366 extracorporeal membrane oxygenation centers from 2013 to 2019.

PATIENTS: Patients older than 18 years supported with a single run of venovenous extracorporeal membrane oxygenation.

INTERVENTIONS: None.

MEASUREMENTS AND MAIN RESULTS: Of 15,872 venovenous extracorporeal membrane oxygenation patients, 812 (5.1%) had at least one type of acute brain injury, defined as ischemic stroke, hemorrhagic stroke, or brain death. Overall, 215 (1.4%) experienced ischemic stroke and 484 (3.1%) experienced hemorrhagic stroke. Overall inhospital mortality was 36%, but rates were higher in those with ischemic or hemorrhagic stroke (68% and 73%, respectively). In multivariable analysis, preextracorporeal membrane oxygenation pH (adjusted odds ratio = 0.10; 95% CI, 0.03-0.35; p < 0.001), hemolysis (adjusted odds ratio = 2.27; 95% CI, 1.22-4.24; p = 0.010), gastrointestinal hemorrhage (adjusted odds ratio = 2.01; 95% CI 1.12-3.59; p = 0.019), and disseminated intravascular coagulation (adjusted odds ratio = 3.61; 95% CI, 1.51-8.66; p = 0.004) were independently associated with ischemic stroke. Pre-extracorporeal membrane oxygenation pH (adjusted odds ratio = 0.28; 95% CI, 0.12-0.65; p = 0.003), preextracorporeal membrane oxygenation Po2 (adjusted odds ratio = 0.96; 95% CI, 0.93-0.99; p = 0.021), gastrointestinal hemorrhage (adjusted odds ratio = 1.70; 95% CI, 1.15-2.51; p = 0.008), and renal replacement therapy (adjusted odds ratio=1.57; 95% CI, 1.22-2.02; p < 0.001) were independently associated with hemorrhagic stroke.

CONCLUSIONS: Among venovenous extracorporeal membrane oxygenation patients in the Extracorporeal Life Support Organization registry, approximately 5% had acute brain injury. Mortality rates increased two-fold when ischemic or hemorrhagic strokes occurred. Risk factors such as lower pH and hypoxemia during the pericannulation period and markers of coagulation disturbances were associated with acute brain injury. Further research on understanding preextracorporeal membrane oxygenation and on-extracorporeal membrane oxygenation risk factors and the timing of acute brain injury is necessary to develop appropriate prevention and management strategies.

来源:Crit Care Med,查看原文。版权归原作者所有。

参考来源

  1. Cho SM, Canner J, Caturegli G, et al. Risk Factors of Ischemic and Hemorrhagic Strokes During Venovenous Extracorporeal Membrane Oxygenation: Analysis of Data From the Extracorporeal Life Support Organization Registry. Crit Care Med. 2021. PMID: 33148951. doi:10.1097/CCM.0000000000004707

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。